Figure 11
In vitro antitumor activity (IC50) of the ligand, DBAPB, and its Cu(II) complexes and their restudies against HepG-2 cells.
Figure 11 | Scientific Reports
In vitro antitumor activity (IC50) of the ligand, DBAPB, and its Cu(II) complexes and their restudies against HepG-2 cells.
